$212.85
0.750.35%
At Close: -
$212.89
0.040.02%
After Hours: Sep 20, 4:06 PM EDT
15 minutes delayed
Comments
Loading...
Inspire Medical Systems (NYSE:INSP) Stock, Earnings Estimates, EPS, And Revenue
Inspire Medical Systems reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS Estimate
$0.090
Quarterly Revenue Estimate
$197.5M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$705.7M
Analyze the earnings history of Inspire Medical Systems using advanced sorting and filters.
Data brought to you by Benzinga APIs
Inspire Medical Systems (INSP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-06 | $0.32 | $-0.15 | 313.3 % |
| Mar 2024 | 2024-05-07 | $-0.34 | $-0.65 | 47.7 % |
| Dec 2023 | 2024-02-06 | $0.49 | $-0.10 | 590.0 % |
| Sep 2023 | 2023-11-07 | $-0.29 | $-0.58 | 50.0 % |
Inspire Medical Systems (INSP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-06 | $195.89M | $186.19M | 5.21 % |
| Mar 2024 | 2024-05-07 | $164.01M | $161.31M | 1.67 % |
| Dec 2023 | 2024-02-06 | $192.51M | $187.24M | 2.81 % |
| Sep 2023 | 2023-11-07 | $153.30M | $153.30M | 0.00 % |
FAQ
When is Inspire Medical Systems (NYSE:INSP) reporting earnings?
Inspire Medical Systems (INSP) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
What were the latest earnings per share (EPS) for Inspire Medical Systems (NYSE:INSP)?
The Actual EPS was $0.32, which beat the estimate of $-0.15.
What were Inspire Medical Systems’s (NYSE:INSP) revenues?
The Actual Revenue was $195.9M, which beat the estimate of $186.2M.
Browse earnings estimates, EPS, and revenue on all stocks.